Virulence attenuated bacteria for treatment of malignant solid tumors
The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a subject. 本发明涉及重组减毒革兰氏阴性细菌菌株，其用于治疗受试者的恶性实体肿瘤的方法中。
Saved in:
| Main Authors | , , , |
|---|---|
| Format | Patent |
| Language | Chinese English |
| Published |
31.08.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a subject.
本发明涉及重组减毒革兰氏阴性细菌菌株，其用于治疗受试者的恶性实体肿瘤的方法中。 |
|---|---|
| AbstractList | The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a subject.
本发明涉及重组减毒革兰氏阴性细菌菌株，其用于治疗受试者的恶性实体肿瘤的方法中。 |
| Author | CORNELIS GUY R AMSTUTZ MARLISE ITTIG SIMON KASPER CHRISTOPH |
| Author_xml | – fullname: KASPER CHRISTOPH – fullname: AMSTUTZ MARLISE – fullname: CORNELIS GUY R – fullname: ITTIG SIMON |
| BookMark | eNqNyk0KwjAQhuEsdOHfHcYDCGoLdiul4sqVuC1j-6UEkklJJvfXhQdw9fLAuzYLiYKV6V4uFQ8ZQKwKKawY6c2DIjkmGxNpAmuAKEVLgb2bhL_I0buRtISY8tYsLfuM3a8bs791z_Z-wBx75JkHCLRvH6djU1_OVd1cq3-eD07jNXs |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 用于治疗恶性实体肿瘤的减毒细菌 |
| ExternalDocumentID | CN108472348A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CN108472348A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:47:23 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Chinese English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CN108472348A3 |
| Notes | Application Number: CN201680079454 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180831&DB=EPODOC&CC=CN&NR=108472348A |
| ParticipantIDs | epo_espacenet_CN108472348A |
| PublicationCentury | 2000 |
| PublicationDate | 20180831 |
| PublicationDateYYYYMMDD | 2018-08-31 |
| PublicationDate_xml | – month: 08 year: 2018 text: 20180831 day: 31 |
| PublicationDecade | 2010 |
| PublicationYear | 2018 |
| RelatedCompanies | UNIVERSITAT BASEL |
| RelatedCompanies_xml | – name: UNIVERSITAT BASEL |
| Score | 3.2826414 |
| Snippet | The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Virulence attenuated bacteria for treatment of malignant solid tumors |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180831&DB=EPODOC&locale=&CC=CN&NR=108472348A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwjSt6Frs7V7KOLSliGsGzLH3kaWNLPC2rG1CP71XrovX_QtJCQkRy65S-73O4AHqhxqUmXWuGPzGhW2prxFn0dISzSsVtSkdQ0U7obNzjt9HTVGJfjcYGEKntCvghwRNUqgvmfFeT3fPWJ5RWzl8nESY1X6HAxcz1h7x3VHJ84yvLbr93tejxmMuSw0wje0dfEYNi3qvOzBPprRtg7_8odtjUqZ_75SghM46ONoSXYKpe-PChyxTea1Chx21x_eWFzr3vIM_GG8yAuIENGcmEmO3SWZrNiWOUHjk2yjxkmqyAwt7KkOcyG4vWJJsnyWLpbncB_4A9ap4XzG28WPWbibunUB5SRNoksgLVuoJydSwpYWlUJxdKMkVyaVdYsL3ryC6t_jVP9rvIZjLcjVu-kNlLNFHt3ixZtN7gqJ_QAfQIk2 |
| link.rule.ids | 230,309,783,888,25578,76884 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUYP4VROzN6JshY0HYqQbQYVBDBLeSGlXxYSNwBYT_3qv48sXfWvatGkvvfauvd_vAG6pcqhJlVnijs1LVNia8hZ9HiEtUbFqQZWWNVC441dbb_R5WBlm4HONhUl5Qr9SckTUKIH6Hqfn9Wz7iOWmsZWLu_EEq6KHZr_uGivvuOzoxFmG26h7va7bZQZjdeYb_ivaungMmxZ1HndgF01sR_Pse4OGRqXMfl8pzUPY6-FoYXwEme-PPOTYOvNaHvY7qw9vLK50b3EM3mAyT1KIENGcmGGC3SUZL9mWOUHjk2yixkmkyBQt7Hcd5kJwe00kiZNpNF-cwE3T67NWCecz2ix-xPzt1K1TyIZRGBSA1Gyh7p1ACVtaVArF0Y2SXJlUli0uePUMin-PU_yv8RpyrX6nPWo_-S_ncKCFunxDvYBsPE-CS7yE4_FVKr0ftlCMJg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Virulence+attenuated+bacteria+for+treatment+of+malignant+solid+tumors&rft.inventor=KASPER+CHRISTOPH&rft.inventor=AMSTUTZ+MARLISE&rft.inventor=CORNELIS+GUY+R&rft.inventor=ITTIG+SIMON&rft.date=2018-08-31&rft.externalDBID=A&rft.externalDocID=CN108472348A |